NIH-funded research R01 grant

Understanding how α-synuclein affects brain wiring in Parkinson’s and related diseases

Official title: Mechanisms of Synaptic Dysfunction in Parkinson s and Other Synuclein-Linked Diseases

Funded at Marine Biological Laboratory · NIH-11361536 · Data updated 2026-11-12

Researchers are studying how clumps of a protein called α-synuclein disrupt communication between brain cells in conditions like Parkinson’s disease, DLB, and some forms of Alzheimer’s, with the aim of finding ways to reverse the damage.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMarine Biological Laboratory
NIH-funded
Lab location1 site (Woods Hole, United States)
Project startJanuary 15, 2012
Project endMay 31, 2027
Funding year2026
Award (this year)$575,609
NIH project number5R01NS078165-14
Project IDNIH-11361536 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people with Parkinson’s disease, dementia with Lewy bodies, or Alzheimer’s disease variants where α-synuclein pathology is present, potentially benefiting from future therapies targeting synaptic function.

Less likely to help

Patients without synuclein-related brain changes or participation in future clinical trials may not directly benefit.

What this research studies

The project uses a model system based on lamprey neurons to explore how α-synuclein build-up at synapses interferes with synaptic vesicle trafficking and endocytosis. It builds on prior findings that excess α-synuclein can block synaptic recycling, and that different forms of the protein have distinct effects. By uncovering the cellular and molecular mechanisms, the work aims to identify strategies to restore normal synaptic function in affected individuals.

Why it matters

Potential benefit: If successful, the research could lead to treatments that improve communication between brain cells and slow or reverse cognitive symptoms in patients with PD, DLB, and related Alzheimer’s variants.

How similar studies have gone: Previous studies using α-synuclein models have demonstrated that modulating synaptic endocytosis can affect function, supporting a translational path though further work is needed.

Where this research is happening

  • Marine Biological Laboratory
    Woods Hole, United States
    Active

Researchers

  • Principal investigator: Morgan, Jennifer Rebecca — Marine Biological Laboratory
  • Study coordinator: Morgan, Jennifer Rebecca

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.